GNNSF 財務： Genscript Biotech Corp AI 分析

Q: Genscript Biotech Corp 的關鍵財務報表是什麼？

根據最新的財務報表（Form-10K），Genscript Biotech Corp 的總資產為 $0，淨利潤為 $2,961

Q: GNNSF 的關鍵財務比率是什麼？

Genscript Biotech Corp 的流動比率為 0，淨利潤率為 498.48，每股銷售為 $0.28。

Q: Genscript Biotech Corp 的收入按細分市場或地理位置如何劃分？

Genscript Biotech Corp 最大收入來源為 Life-science Services and Products，在最近的收益報告中收入為 3,516,279,684。就地區而言，United States 是 Genscript Biotech Corp 的主要市場，收入為 2,068,502,630。

Q: Genscript Biotech Corp 是否盈利？

是的，根據最新的財務報表，Genscript Biotech Corp 的淨利潤為 $2,961

Q: Genscript Biotech Corp 有負債嗎？

無，Genscript Biotech Corp 的負債為 0

Q: Genscript Biotech Corp 的流通股有多少？

Genscript Biotech Corp 的總流通股為 0

首頁

股票

GNNSF

GNNSF 財務

Genscript Biotech Corp

$1.84

收盤價：Jan 16, 16:00:00 GMT-5

$1.84

盤後：Jan 16, 20:00:00 GMT-5

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

GNNSF 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	551	594	560	625	490	390
營收年增率 (YoY)	21%	6%	-10%	28%	26%	43%
營收成本	266	322	289	321	207	134
毛利	285	272	270	304	282	255
銷售、一般及管理費用	97	209	191	351	303	197
研發	-151	53	52	390	358	263
營業費用	-51	380	109	735	804	462
其他非營業收入 (費用)	-8	-4	-3	-1	0	-4
稅前淨利	34	-170	168	-431	-517	-281
所得稅費用	17	2	6	-3	0	0
淨利	3,111	2,961	-95	-226	-358	-204
淨利成長	-1,857.99%	-3,217%	-57.99%	-37%	75%	112.99%
稀釋後流通股數	2,154.85	2,121.28	2,109.36	2,104.12	2,039.2	1,900.78
股數年變動 (YoY)	2%	1%	0%	3%	7%	2%
每股盈餘 (稀釋)	1.44	1.39	-0.04	-0.1	-0.17	-0.1
每股盈餘成長率	-1,900%	-3,575%	-63%	-39%	63%	107%
自由現金流	141	-72	-444	-323	-274	-278
每股自由現金流	--	--	--	--	--	--
毛利率	51.72%	45.79%	48.21%	48.64%	57.55%	65.38%
營業利益率	60.98%	-18.18%	28.57%	-68.96%	-106.53%	-52.82%
淨利率	564.6%	498.48%	-16.96%	-36.16%	-73.06%	-52.3%
自由現金流利潤率	25.58%	-12.12%	-79.28%	-51.68%	-55.91%	-71.28%
EBITDA	408	-31	233	-367	-475	-174
EBITDA 利潤率	74.04%	-5.21%	41.6%	-58.72%	-96.93%	-44.61%
EBITDA 中的折舊與攤銷	72	77	73	64	47	32
EBIT	336	-108	160	-431	-522	-206
EBIT 利潤率	60.98%	-18.18%	28.57%	-68.96%	-106.53%	-52.82%
有效稅率	50%	-1.17%	3.57%	0.69%	0%	0%

Follow-Up Questions

Genscript Biotech Corp 的關鍵財務報表是什麼？



GNNSF 的關鍵財務比率是什麼？



Genscript Biotech Corp 的收入按細分市場或地理位置如何劃分？



Genscript Biotech Corp 是否盈利？



Genscript Biotech Corp 有負債嗎？



Genscript Biotech Corp 的流通股有多少？



關鍵數據

前收市價

$1.84

開盤價

$1.84

當日範圍

$1.84 - $1.84

52週區間

$1.2 - $2.42

交易量

20.0K

平均成交量

653

每股盈餘 (TTM)

-0.04

股息收益率

市值

$4.0B

什麼是 GNNSF？

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu and currently employs 5,769 full-time employees. The company went IPO on 2015-12-30. The firm operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The firm mainly operates its businesses in the domestic and overseas markets.

功能特性

交易策略